Oxethazaine-d6 structure
|
Common Name | Oxethazaine-d6 | ||
---|---|---|---|---|
CAS Number | 1346603-51-7 | Molecular Weight | 473.68 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C28H35D6N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Oxethazaine-d6Oxethazaine-d6 (Oxetacaine-d6) is the deuterium labeled Oxethazaine. Oxethazaine (Oxetacaine), a precursor of phentermine acidic, is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated with peptic ulcer disease or esophagitis[1][2]. |
Name | Oxethazaine-d6 |
---|
Description | Oxethazaine-d6 (Oxetacaine-d6) is the deuterium labeled Oxethazaine. Oxethazaine (Oxetacaine), a precursor of phentermine acidic, is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated with peptic ulcer disease or esophagitis[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C28H35D6N3O3 |
---|---|
Molecular Weight | 473.68 |